This excerpt taken from the ASGN 8-K filed Aug 5, 2008.
Item 8.01 Other Events
On August 4, 2008 registrant filed a Form 8-K pursuant to Item 2.02 containing as an exhibit a press release disclosing material non-public information regarding the registrants results of operations for the quarter ended June 30, 2008. The purpose of this Amended Form 8-K is to correct certain information contained in that previously filed Form 8-K pursuant to Item 2.02; specifically to correct: (i) the weighted average common and common equivalent shares outstanding diluted for the six months ended June 30, 2008 from 34,241 to 35,612; (ii) the diluted earnings per share for the six months ended June 30, 2008 from $0.25 to $0.24; (iii) the interest expense (net) per share for the six months ended June 30, 2008 from $0.19 to $0.18; (iv) EBITDA per share for the six months ended June 30, 2008 from $.078 to $0.75; (v) equity-based compensation per share for the six months ended June 30, 2008 from $0.10 to $0.09; and (vi) Adjusted EBITDA per share for the six months ended June 30, 2008 from $0.88 to $0.84.
Corrected versions of the Summary Consolidated Statements of Operations table and the Reconciliation of GAAP Net Income and Earnings Per Share to Non-GAAP EBITDA and EBITDA Per Share table are furnished with this Current Report on Form 8-K/A as Exhibit 99.1
This excerpt taken from the ASGN 8-K filed Nov 15, 2006.
Item 8.01 Other Events.
On November 9, 2006, On Assignment, Inc. (the Company) entered into an underwriting agreement with UBS Securities LLC, SunTrust Capital Markets, Inc., BMO Capital Markets Corp. and Ryan Beck & Co. Inc., as the representatives of the several underwriters named therein, for the sale by the Company to the public of 6,650,000 shares of its common stock, par value $0.01 per share, at a public offering price of $10.00 per share. The offering is scheduled to close on November 15, 2006, subject to customary closing conditions. The Company has granted the underwriters an option exercisable for thirty days after the date of the underwriting agreement to purchase 997,500 additional shares of its common stock to cover over-allotments. On November 10, 2006 the underwriters exercised the over-allotment option with respect to 993,141 shares of common stock of the Company. The underwriting agreement is filed as Exhibit 1.1 hereto and is incorporated herein by this reference.